Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6453415 | 0.91 | TLR4 (0.64) | TLR4CYP19A1MAPTLMNA | |
| SCHEMBL6453405 | 0.91 | TLR4 (0.64) | TLR4CYP19A1MAPTLMNA | |
| SCHEMBL6157017 | 0.91 | TLR4 (0.64) | TLR4CYP19A1MAPTLMNA | |
| SCHEMBL6458053 | 0.84 | TLR4 (0.56) | TLR4 | |
| SCHEMBL6458057 | 0.84 | TLR4 (0.56) | TLR4 | |
| SCHEMBL11062755 | 0.84 | CYP1A2 (0.38) | TLR4CYP1A2CYP19A1CCR2MAPT | |
| SCHEMBL10450736 | 0.82 | TLR4 (0.44) | TLR4CYP1A2CYP19A1CCR2MEN1 | |
| SCHEMBL10450737 | 0.82 | TLR4 (0.44) | TLR4CYP1A2CYP19A1CCR2MEN1 | |
| SCHEMBL10450733 | 0.82 | TLR4 (0.44) | TLR4CYP1A2CYP19A1CCR2MEN1 | |
| SCHEMBL10450382 | 0.81 | TLR4 (0.43) | TLR4CYP1A2CYP19A1CCR2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8092711-B2 | Liquid crystal compound, polymerizable liquid crystal composition, optically anisotropic material, optical element and optical information writing/reading device | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20110069241-A1 | LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-2295397-A1 | LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL INFORMATION RECORDING/PLAYBACK DEVICE | Asahi Glass Company, Limited (JP) | 2011-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110069241-A1 | LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL INFORMATION WRITING/READING DEVICE | CCNE2, CCND1, CCNT1 | TLR4 3725/4885CYP1A2 1252/4885CYP19A1 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.